EQUITY (Tables)

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Schedule of Warrants Outstanding and Exercisable

The following table summarizes the status of warrants and related transactions:

	Non-Derivative (Equity) Warrants	Derivative Liabilities Warrants (1)	Total Number of Warrants	Weighted - Average Exercise Price
Balance as of January 1, 2023	30,673,635	55,375,202	86,048,837	$	1.40
Granted	851,471	—	851,471	$	0.61
Cancelled/forfeited/expired	(337,500)	—	(337,500)	$	1.49
Reclassification	17,512,280	(17,512,280)	—	$	—
Balance as of September 30, 2023	48,699,886	37,862,922	86,562,808	$	1.16
Exercisable as of September 30, 2023	46,524,886	37,862,922	84,387,808	$	1.14

(1)In June 2023, 5,890,000 warrants were repriced from $1.25 to $1.00. Additionally, 17,512,280 warrants were reclassified from derivative liability warrants to non-derivative (equity) warrants and repriced from $2.086 to $1.00. Refer to Note 11 - Derivative Liabilities for additional information.

Summary of Stock Options Outstanding

The following table summarizes the status of stock options and related transactions:

	Number of Stock Options	Weighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 2023	30,752,259	$	2.58
Granted	4,112,000	$	0.51
Cancelled/forfeited/expired	(6,490,171)	$	2.60
Issued and Outstanding as of September 30, 2023	28,374,088	$	2.27
Exercisable as of September 30, 2023	17,364,078	$	2.49

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The following assumptions were used for the calculation at date of grant:

	Nine Months Ended September 30,
	2023	2022
Weighted average stock price	$0.51	$2.02
Weighted average expected stock price volatility	76.9%	73.1%
Expected annual dividend yield	0%	0%
Weighted average expected life	6.0 years	5.8 years
Weighted average risk-free annual interest rate	3.6%	2.6%
Weighted average grant date fair value	$0.34	$1.45

Nonvested Restricted Stock Shares Activity

The following table summarizes the status of restricted stock and related transactions:

	Number of Restricted Subordinate Voting Shares
Unvested restricted stock as of January 1, 2023	1,156,319
Cancelled/forfeited	(54,774)
Vested and Released	(1,099,684)
Unvested restricted stock as of September 30, 2023	1,861

Components of Share-based Compensation Expense

The components of share-based compensation expense are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Stock options	$	712	$	4,569	$	4,170	$	14,369
Restricted stock	—		347		293		1,625
Warrants	344		550		1,267		1,120
Total share-based compensation expense	$	1,056	$	5,466	$	5,730	$	17,114